David Cox, Author at Labiotech.eu

About

David Cox is a science and health writer based in the UK. He has a PhD in neuroscience from the University of Cambridge and has written for newspapers and broadcasters worldwide including the BBC, New York Times, and The Guardian. You can follow him on Twitter @DrDavidACox.

Articles by David Cox

Best in Biotech 6 Jun 2023

Ten Swedish companies spearheading the country’s biotech scene

Known for its abundant forests, smorgasbords and not to mention the famed Europop group ABBA, Sweden has a thriving economy that largely depends on manufacturing and exports. And the country’s…

June 6, 2023 - 10 minutesmins - By David Cox

In Depth 15 Aug 2022

Can phage therapy answer the booming antibiotic resistance problem?

Antibiotic-resistant superbugs cause a large number of deaths around the world each year, but effective new antibiotics are thin on the ground. Could bacteria-eating phage viruses be the answer to…

August 15, 2022 - 8 minutesmins - By David Cox

In Depth 18 Oct 2021

Could We See a New Dawn for Hair Loss Treatments?

There hasn’t been a new hair loss drug approved in twenty years. But a number of European companies are hot on the case and are getting tantalizingly close to the…

October 18, 2021 - 7 minutesmins - By David Cox

In Depth 22 Mar 2021

Can Immunotherapy Offer Hope for Parkinson’s Sufferers?

Despite decades of research, effective treatments for Parkinson’s disease are proving elusive. Could immunotherapy finally provide a solution? More than seven million people worldwide are currently living with Parkinson’s disease,…

March 22, 2021 - 5 minutesmins - By David Cox

In Depth 15 Jun 2020

Drug Development in Covid-19 Times: Is Going Remote the Answer?

With the coronavirus pandemic forcing scientific research labs to close around the globe, it seems almost inevitable that the ongoing crisis will accelerate the growing demand for remote drug development.…

June 15, 2020 - 7 minutesmins - By David Cox

In Depth 4 Jun 2019

Ultra-Fast Diagnostics Could Transform Sexual Health

Each day more than one million people around the world acquire sexually transmitted infections, with a profound impact on sexual and reproductive health across the globe. Biotechs across Europe are…

June 4, 2019 - 7 minutesmins - By David Cox

Best in Biotech 8 May 2019

Top 10 Biotechs in Lausanne

The Swiss city of Lausanne is perhaps best known as a hub of international sport, but what many outsiders may not realize is that it’s also one of Switzerland’s biggest…

May 8, 2019 - 7 minutesmins - By David Cox

Best in Biotech 5 Mar 2019

5 Biotech Industry Challenges the EU’s Horizon Program Plans to Tackle

While the EU’s Horizon funding program is more often associated with academic research, a sizeable proportion of its funds are invested in the European biotech industry. With a new stage…

March 5, 2019 - 9 minutesmins - By David Cox

Best in Biotech 18 Feb 2019

10 European Genomics Companies to Watch Out For

Next generation sequencing has revolutionized the biotech industry and genomics technology has changed dramatically over the last few years. There are many interesting European genomics companies, but here are 10…

February 18, 2019 - 8 minutesmins - By David Cox

In Depth 1 Oct 2018

Could These Innovative Flu Vaccines Prevent Deaths From Deadly Outbreaks?

Despite more than a century of scientific endeavour, influenza remains one of the most deadly infectious diseases worldwide. Across Europe, many biotechs are working on novel solutions that could dramatically…

October 1, 2018 - 8 minutesmins - By David Cox

Beyond Biotech - the podcast from Labiotech

View More

Newsletter Signup - Sidebar

"*" indicates required fields

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

View all companies A-Z

Partner with world-leading academics working on sustainable materials R&D

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inpart, the leading platform for biopharma partnering